Direct promoter repression by BCL11A controls the fetal to adult hemoglobin switch

Liu, Nan, Hargreaves, Victoria V., Zhu, Qian, Kurland, Jesse V., Hong, Jiyoung, Kim, Woojin, Sher, Falak, Macias-Trevino, Claudio +8 more·2018·Cell

Cited by (477)

Items 201–300 of 477

  1. HEXIM1 is an essential transcription regulator during human erythropoiesis
    Xiurui Lv, Kristin E. Murphy, Zachary C. Murphy, Michael R. Getman, Nabil F. Rahman, Yukio Nakamura, Lionel Blanc, Patrick G. Gallagher, James Palis, Narla Mohandas et al. · 2023 · Blood
  2. Targeted Protein Degradation as a Promising Tool for Epigenetic Upregulation of Fetal Hemoglobin
    Thijs C. J. Verheul, Van Tuan Trinh, Olalla Vázquez, Sjaak Philipsen · 2020 · ChemMedChem
  3. CRISPR Gene Therapy: A Promising One-Time Therapeutic Approach for Transfusion-Dependent β-Thalassemia—CRISPR-Cas9 Gene Editing for β-Thalassemia
    Udani Gamage, Kesari Warnakulasuriya, Sonali Hansika, Gayathri N. Silva · 2023 · Thalassemia Reports
  4. Removal of promoter CpG methylation by epigenome editing reverses HBG silencing
    Henry William Bell, Ruopeng Feng, Manan Shah, Yu Yao, James Douglas, Phillip A. Doerfler, Thiyagaraj Mayuranathan, Michael F O'Dea, Yichao Li, Yong‐Dong Wang et al. · 2025 · Nature Communications
  5. Role of Nuclear Receptors in Controlling Erythropoiesis
    Valentina Pastori, Serena Pozzi, Agata Łabędź, Sajeela Ahmed, Antonella Ellena Ronchi · 2022 · International Journal of Molecular Sciences
  6. Cell-type specific profiling of histone post-translational modifications in the adult mouse striatum
    Marco D. Carpenter, Delaney K. Fischer, Shuo Zhang, Allison M. Bond, Kyle S. Czarnecki, Morgan T. Woolf, Hongjun Song, Elizabeth A. Heller · 2022 · Nature Communications
  7. Bcl11a maintains hematopoietic stem cell function but accelerates inflammation-driven exhaustion during aging.
    Jing Wang, Lin-Lin Zhang, Xinyu Cui, Xiang Xu, Rui Guo, Kairui Li, Li Zhang, Bing Xu, Ci-Zhong Jiang, Yong Yu · 2025 · Science immunology
  8. Potential role of LSD1 inhibitors in the treatment of sickle cell disease: a review of preclinical animal model data
    Angela E. Rivers, Ramasamy Jagadeeswaran, Donald Lavelle · 2018 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  9. Effective therapies for sickle cell disease: are we there yet?
    Merlin Crossley, Georgios E. Christakopoulos, Mitchell J. Weiss · 2022 · Trends in Genetics
  10. GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression
    Rebecca Reese, Kyle T. Helzer, Kaelyn O Allen, Christy Zheng, Natalia M. Solodin, Elaine T. Alarid · 2022 · Molecular and Cellular Biology
  11. Genetic comparison of sickle cell anaemia cohorts from Brazil and the United States reveals high levels of divergence
    Pedro Rodrigues Sousa da Cruz, Galina Ananina, Vera Lúcia Gil‐da‐Silva‐Lopes, Milena Simioni, Farid Menaa, Marcos André Cavalcanti Bezerra, Igor F. Domingos, Aderson Silva Araujo, Renata Pellegrino, Hakon H. Hakonarson et al. · 2019 · Scientific Reports
  12. Transcriptomic and epigenomic dynamics associated with development of human iPSC-derived GABAergic interneurons
    George Andrew S. Inglis, Ying Zhou, Dillon G. Patterson, Christopher D. Scharer, Yanfei Han, Jeremy M. Boss, Zhexing Wen, Andrew Escayg · 2020 · Human Molecular Genetics
  13. Endogenous bioluminescent reporters reveal a sustained increase in utrophin gene expression upon EZH2 and ERK1/2 inhibition
    Hannah J. Gleneadie, Beatriz Fernandez-Ruiz, Alessandro Sardini, Mathew Van de Pette, Andrew Dimond, Rab K. Prinjha, James McGinty, P. M. W. French, Hakan Bagci, Matthias Merkenschlager et al. · 2023 · Communications Biology
  14. AgRP neuron cis-regulatory analysis across hunger states reveals that IRF3 mediates leptin’s acute effects
    Frankie D. Heyward, Nan Liu, Christopher L. Jacobs, Rachael Ivison, Natalia Machado, Aykut Göktürk Üner, Harini Srinivasan, Suraj J. Patel, Anton Gulko, Tyler J. Sermersheim et al. · 2024 · Nature Communications
  15. FRA1 controls acinar cell plasticity during murine KrasG12D induced pancreatic acinar to ductal metaplasia
    Alina L. Li, Kensuke Sugiura, Noriyuki Nishiwaki, Kensuke Suzuki, Dorsay Sadeghian, Jun Zhao, A. Maitra, David Falvo, R. Chandwani, Jason R. Pitarresi et al. · 2024 · Developmental Cell
  16. Enhancer regulatory networks globally connect non-coding breast cancer loci to cancer genes
    Yihan Wang, Daniel A. Armendariz, Lei Wang, Huan Zhao, Shiqi Xie, Gary C. Hon · 2025 · Genome biology
  17. Pharmacologic induction of PGC ‐1α stimulates fetal haemoglobin gene expression
    Yanan Sun, Alawi H. Habara, Cuong Quang Le, Nicole Nguyen, Raymon Chen, George J. Murphy, David H.K. Chui, Martin H. Steinberg, Shuaiying Cui · 2022 · British Journal of Haematology
  18. Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells
    Haokun Zhang, Qinlinglan Zhou, Hongyan Chen, Daru Lu · 2022 · International Journal of Molecular Sciences
  19. Physical interaction between MSL2 and CLAMP assures direct cooperativity and prevents competition at composite binding sites
    Nikolas Eggers, Fotios Gkountromichos, Silke Krause, Aline Campos Sparr, Peter B. Becker · 2023 · Nucleic Acids Research
  20. Gene therapy and gene editing strategies in inherited blood disorders
    Xuemei Song, JinLei Liu, Tangcong Chen, Tingfeng Zheng, Xiaolong Wang, Xiang Guo · 2024 · Journal of genetics and genomics/Journal of Genetics and Genomics
  21. Transcriptional Repressor BCL11A in Erythroid Cells
    Ge Zheng, Stuart H. Orkin · 2024 · Advances in experimental medicine and biology
  22. Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12
    Selina Troester, Thomas Eder, Nadja Wukowits, Martin Piontek, Pablo Fernández‐Pernas, Johannes Schmoellerl, Ben Haladik, Gabriele Manhart, Melanie Allram, Margarita Maurer‐Granofszky et al. · 2025 · Nature Communications
  23. Heterogeneity of fetal hemoglobin production in adult red blood cells
    Eugene Khandros, Gerd A. Blobel · 2021 · Current Opinion in Hematology
  24. Identification of in vivo Hox13-binding sites reveals an essential locus controlling zebrafish brachyury expression
    Zhi Ye, Christopher R. Braden, Andrea Elizabeth Wills, David Kimelman · 2021 · Development
  25. Three children with different de novo BCL11A variants and diverse developmental phenotypes, but shared global motor discoordination and apraxic speech: Evidence for a functional gene network influencing the developing cerebellum and motor and auditory cortices
    Laurel Bruce, Beate Peter · 2022 · American Journal of Medical Genetics Part A
  26. The DNA repair function of BCL11A suppresses senescence and promotes continued proliferation of triple-negative breast cancer cells
    Elise Vickridge, Camila Cristina Fraga Faraco, Payman Samavarchi‐Tehrani, Zubaidah M. Ramdzan, Billel Djerir, Hedyeh Rahimian, Lam Leduy, Alexandre Maréchal, Anne‐Claude Gingras, Alain Nepveu · 2022 · NAR Cancer
  27. RNA in Therapeutics: CRISPR in the Clinic
    Dana Carroll · 2022 · Molecules and Cells
  28. Combinatorial targeting of epigenome-modifying enzymes with decitabine and RN-1 synergistically increases HbF
    Vinzon Ibañez, Kestis Vaitkus, Xu Zhang, Ramasamy Jagadeeswaran, Angela E. Rivers, Yogen Saunthararajah, Robert E. Molokie, Donald Lavelle · 2023 · Blood Advances
  29. Hit and Run Transcriptional Repressors Are Difficult to Catch in the Act
    Manan Shah, Alister P. W. Funnell, Kate G R Quinlan, Merlin Crossley · 2019 · BioEssays
  30. Gene Therapy as the New Frontier for Sickle Cell Disease
    Himanshu Garg, Kristina J. Tatiossian, Karsten Peppel, Gregory James Kato, Eva Herzog · 2021 · Current Medicinal Chemistry
  31. Hemoglobinopathies and Thalassemias
    Scott A. Peslak, Farzana A. Sayani · 2022 · Elsevier eBooks
  32. Transcriptional network governing extraembryonic endoderm cell fate choice
    Paula Duyen Pham, Hanbin Lu, Han Han, Jeff Jiajing Zhou, Aarushi Madan, Wenqi Wang, Cornelis Murre, Ken W.Y. Cho · 2023 · Developmental Biology
  33. Base editing of key residues in the BCL11A-XL-specific zinc finger domains derepresses fetal globin expression
    Vignesh Rajendiran, Nivedhitha Devaraju, Mahdi Haddad, Nithin Sam Ravi, Lokesh Panigrahi, Joshua Paul, Chandrasekar Gopalakrishnan, Stacia K. Wyman, Keerthiga Ariudainambi, Gokulnath Mahalingam et al. · 2024 · Molecular Therapy
  34. A single-cell atlas of chromatin accessibility in mouse organogenesis
    Keyong Sun, Xin Liu, Xun Lan · 2024 · Nature Cell Biology
  35. PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease
    Yanan Sun, Hajar Benmhammed, Salam Al Abdullatif, Alawi H. Habara, Eric Fu, Jordan Brady, Christopher Williams, Adrian Ilinski, Anusha Sharma, Kiana Mahdaviani et al. · 2024 · Science Advances
  36. Nucleic Acid Therapy for β-Thalassemia
    Annette d’Arqom · 2020 · Biologics
  37. Genetic research and clinical analysis of β‐globin gene cluster deletions in the Chinese population of Fujian province: A 14‐year single‐center experience
    Meihuan Chen, Min Zhang, Lingji Chen, Na Lin, Yan Wang, Liangpu Xu, Hailong Huang · 2021 · Journal of Clinical Laboratory Analysis
  38. Down-regulation of the transcriptional repressor ZNF802 (JAZF1) reactivates fetal hemoglobin in β0-thalassemia/HbE
    Chokdee Wongborisuth, Sukanya Chumchuen, Orapan Sripichai, Usanarat Anurathapan, Nuankanya Sathirapongsasuti, Duantida Songdej, Amornrat Tangprasittipap, Suradej Hongeng · 2022 · Scientific Reports
  39. A functional map of genomic HIF1α-DNA complexes in the eye lens revealed through multiomics analysis
    Joshua Disatham, Lisa Brennan, Daniel Chauss, Jason Kantorow, Behdad Afzali, Marc Kantorow · 2021 · BMC Genomics
  40. Physiological and Aberrant γ-Globin Transcription During Development
    Gloria Barbarani, Agata Łabędź, Sarah Stucchi, Alessia Abbiati, Antonella Ellena Ronchi · 2021 · Frontiers in Cell and Developmental Biology
  41. In situ tools for chromatin structural epigenomics
    Steven Henikoff, Kami Ahmad · 2022 · Protein Science
  42. Dissection of the MEF2D-IRF8 transcriptional circuit dependency in acute myeloid leukemia
    Bianca Y. Pingul, Hua Huang, Qingzhou Chen, Fatemeh Alikarami‬, Zhen Zhang, Jun Qi, Kathrin Maria Bernt, Shelley L. Berger, Zhendong Cao, Junwei Shi · 2022 · iScience
  43. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases
    Shuangping Ma, Yiran Qin, Wenjie Ren · 2024 · Molecular Medicine
  44. BPDCN MYB fusions regulate cell cycle genes, impair differentiation, and induce myeloid–dendritic cell leukemia
    Christopher A.G. Booth, Juliette Bouyssou, Katsuhiro Togami, Olivier Armand, Hembly G. Rivas, Kezhi Yan, Siobhan Rice, Shuyuan Cheng, Emily M. Lachtara, Jean‐Pierre Bourquin et al. · 2024 · JCI Insight
  45. The transcription factor ZNF469 regulates collagen production in liver fibrosis
    Sebastian Steinhauser, David Estoppey, Dennis P. Buehler, Yanhua Xiong, Nicolas Pizzato, Amandine Rietsch, Fabian Wu, Nelly Leroy, Tiffany Wunderlin, Isabelle Claerr et al. · 2025 · JCI Insight
  46. Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling
    Krystal A. Orlando, Sara A. Grimm, Paul A. Wade · 2025 · Nucleic Acids Research
  47. Progress and prospect of minicircle as a minimized non-viral DNA vector in gene therapy and regenerative medicine
    Pegah Chanani, Naeimeh Rezaei, Kianoush Dormiani, Mona Shokatian, Nafiseh Sanei Ata-abadi · 2025 · Molecular Therapy — Nucleic Acids
  48. Engineering Globin Gene Expression
    Rachael Davis, Aishwarya Gurumurthy, Mir Ahamed Hossain, Eliot M. Gunn, Jörg Bungert · 2018 · Molecular Therapy — Methods & Clinical Development
  49. Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia
    William M. Yashar, Brittany M. Curtiss, Daniel J. Coleman, Jake VanCampen, Garth Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly et al. · 2023 · Molecular Cancer Research
  50. Exhaustive identification of genome-wide binding events of transcriptional regulators
    Anna Nordin, Pierfrancesco Pagella, Gianluca Zambanini, Claudio Cantù · 2024 · Nucleic Acids Research
  51. Ctrl-Alt-inDel: genome editing to reprogram a cell in the clinic
    Fyodor D. Urnov · 2018 · Current Opinion in Genetics & Development
  52. The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene
    Cristina Fugazza, Gloria Barbarani, Sudharshan Elangovan, Maria Giuseppina Marini, Serena Giolitto, Isaura Font-Monclus, Maria Franca Marongiu, Laura Manunza, John Strouboulis, Claudio Cantù et al. · 2020 · Haematologica
  53. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies
    Charlotte Andrieu‐Soler, Éric Soler · 2020 · Current Opinion in Hematology
  54. A Review of Gene Therapies for Hemoglobinopathies
    Boubini Jones-Wonni, Amar Harry Kelkar, Maureen Achebe · 2024 · Hemoglobin
  55. Prime editing: A gene precision editing tool from inception to present
    Zhihao Liu, Dong Guo, Dawei Wang, Jinglin Zhou, Qi Chen, Junzhong Lai · 2024 · The FASEB Journal
  56. Genome editing strategies for targeted correction of β-globin mutation in sickle cell disease: From bench to bedside
    Henna Butt, Shruti Sathish, Evan London, Taylor Lee Johnson, Khaled Essawi, Alexis Kristine Leonard, John F. Tisdale, Selami Demirci · 2025 · Molecular Therapy
  57. Multimeric transcription factor BCL11A utilizes two zinc-finger tandem arrays to bind clustered short sequence motifs
    John R. Horton, Meigen Yu, Jujun Zhou, Melody L. Tran, Rithvi R Anakal, Yue Lu, Robert Blumenthal, Xiaotian Zhang, Yun Huang, Xing Zhang et al. · 2025 · Nature Communications
  58. Advances in Gene Therapy for Sickle Cell Disease: From Preclinical Innovations to Clinical Implementation and Access Challenges
    Henna Butt, Mamatha Mandava, David Alex Jacobsohn · 2025 · The CRISPR Journal
  59. A large cohort of deletional high hemoglobin F determinants in Thailand: A molecular revisited and identification of a novel mutation
    Kritsada Singha, Wanicha Tepakhan, Supawadee Yamsri, Attawut Chaibunruang, Hataichanok Srivorakun, Anupong Pansuwan, Goonnapa Fucharoen, Supan Fucharoen · 2023 · Clinica Chimica Acta
  60. Increasing the precision of gene editing in vitro, ex vivo, and in vivo
    Katherine P. Mueller, Jared Carlson-Stevermer, Krishanu Saha · 2018 · Current Opinion in Biomedical Engineering
  61. Sickle cell disease in the era of precision medicine: looking to the future
    Martin H. Steinberg, Sara S. Kumar, George J. Murphy, Kim Vanuytsel · 2019 · Expert Review of Precision Medicine and Drug Development
  62. β-Hemoglobinopathies: The Test Bench for Genome Editing-Based Therapeutic Strategies
    Gloria Barbarani, Agata Łabędź, Antonella Ellena Ronchi · 2020 · Frontiers in Genome Editing
  63. Genome-wide profiling of histone modifications in Plasmodium falciparum using CUT&RUN
    Riward Campelo Morillo, Chantal T. Harris, Kit Kennedy, Samuel R Henning, Björn F.C. Kafsack · 2022 · Life Science Alliance
  64. Omics Studies in Hemoglobinopathies
    Eleni Z. Katsantoni · 2019 · Molecular Diagnosis & Therapy
  65. Human genetics implicates a BACH2-NRF2 axis in fetal heamoglobin activation
    C. Guo, Uma P. Arora, Xiaoheng Cheng, Wanying Xu, Liam D. Cato, Rick Li, Henry Y. Lu, Andrew Lee, Fulong Yu, Gaurav Agarwal et al. · 2023 · medRxiv
  66. Dual role of BCL11B in T-cell malignancies
    Grzegorz Krzysztof Przybylski, Julia Przybylska, Yangqiu Li · 2024 · Blood Science
  67. Synaptic activity causes minute-scale changes in BAF complex composition and function
    Sai P. Gourisankar, Sabin A. Nettles, Wendy Wenderski, João A. Paulo, Sam H. Kim, Kyra C Roepke, Claire Ellis, Hind Z. Abuzaid, Steven P. Gygi, Gerald R. Crabtree · 2025 · Molecular Cell
  68. A link between mitochondrial damage and the immune microenvironment of delayed onset muscle soreness
    Zheng Li, Lina Peng, Lili Sun, Juncheng Si · 2023 · BMC Medical Genomics
  69. The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression
    Meihuan Chen, Xinrui Wang, Haiwei Wang, Min Zhang, Lingji Chen, Hong Chen, Yali Pan, Yanhong Zhang, Liangpu Xu, Hailong Huang · 2023 · PLoS ONE
  70. Dual DNA and protein tagging of open chromatin unveils dynamics of epigenomic landscapes in leukemia
    Jonathan D. Lee, João A. Paulo, Ryan R. Posey, Vera Mugoni, Nikki R. Kong, Giulia Cheloni, Yu-Ru Lee, Frank John Slack, Daniel Geoffrey Tenen, John G. Clohessy et al. · 2021 · Nature Methods
  71. Erythroid Cell Research: 3D Chromatin, Transcription Factors and Beyond
    Charlotte Andrieu‐Soler, Éric Soler · 2022 · International Journal of Molecular Sciences
  72. Proteasome Inhibitors Silence Oncogenes in Multiple Myeloma through Localized Histone Deacetylase 3 Stabilization and Chromatin Condensation
    Laure Maneix, Polina A. Iakova, Shannon E. Moree, Joanne I. Hsu, Ragini M. Mistry, Fabio Stossi, Premal Lulla, Zheng Sun, Ergün Sahin, Sarvari Venkata Yellapragada et al. · 2022 · Cancer Research Communications
  73. Transcriptome Analyses of β-Thalassemia −28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs)
    Jing Li, Ziheng Zhou, Hai‐Xi Sun, Wenjie Ouyang, Guoyi Dong, Tianbin Liu, Lei Ge, Xiuqing Zhang, Chao Liu, Ying Gu · 2020 · Frontiers in Genetics
  74. High Expression of BCL11A Predicts Poor Prognosis for Childhood MLL-r ALL
    Lulu Wang, Dehong Yan, Xue Tang, Zhang Mengqi, Shilin Liu, Ying Wang, Min Zhang, Guichi Zhou, Tonghui Li, Feifei Jiang et al. · 2021 · Frontiers in Oncology
  75. Efficient repair of human genetic defect by CRISPR/Cas9-mediated interlocus gene conversion
    Fei Yang, Yiyun Wang, Qiudao Wang, Jingtao Pang, Guolong Liu, Yang Yang, Shenguang Qin, Ying Zhang, Yongrong Lai, Bin Fu et al. · 2023 · Life Medicine
  76. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers
    Marco Jessen, Dörthe Gertzmann, Franziska Liss, Franziska Zenk, Laura Bähner, Victoria Schöffler, Clemens Schulte, Hans Michael Maric, Carsten Patrick Ade, Björn von Eyß et al. · 2024 · Oncogene
  77. CRISPR technology in human diseases
    Qiang Feng, Qirong Li, Hengzong Zhou, Zhan Wang, Chao Lin, Ziping Jiang, Tianjia Liu, Dongxu Wang · 2024 · MedComm
  78. The glucocorticoid receptor elicited proliferative response in human erythropoiesis is BCL11A-dependent
    Maria Mazzarini, Jennifer M. Cherone, Truong Nguyen, Fabrizio Martelli, Lilian Varricchio, Alister P. W. Funnell, Thalia Papayannopoulou, Anna Ritá Migliaccio · 2024 · Stem Cells
  79. THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES
    Ugo Testa, Giuseppe Leone, Maria Domenica Cappellini · 2024 · Mediterranean Journal of Hematology and Infectious Diseases
  80. CRISPR-based gene therapy for the induction of fetal hemoglobin in sickle cell disease
    Meghann Pine McManus, Haydar Frangoul, Martin H. Steinberg · 2024 · Expert Review of Hematology
  81. Protocol to isolate mature thymic T cell subsets using fluorescence-activated cell sorting for assessing gene expression by RNA-seq and transcription factor binding across the genome by CUT&RUN
    Dimitris Theofilatos, Tarmo Äijö, Ageliki Tsagaratou · 2022 · STAR Protocols
  82. Comprehensive Characterization and Global Transcriptome Analysis of Human Fetal Liver Terminal Erythropoiesis
    Yongshuai Han, Shihui Wang, Yaomei Wang, Yumin Huang, Chengjie Gao, Xinhua Guo, Lixiang Chen, Huizhi Zhao, Xiuli An · 2023 · Genomics Proteomics & Bioinformatics
  83. Allogeneic Hematopoietic Stem Cell Transplantation to Cure Transfusion-Dependent Thalassemia: Timing Matters!
    Christina Peters · 2018 · Transplantation and Cellular Therapy
  84. Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model
    Tomohiro Makino, Munetada Haruyama, Katsushi Katayama, Hideki Terashima, Tomoyuki Tsunemi, Kazuo Miyazaki, Maki Terakawa, Kyoko Yamashiro, Ryosuke Yoshioka, Hiroaki Maeda · 2019 · Biochemical Pharmacology
  85. Improved CUT&RUN chromatin profiling and analysis tools
    Michael P. Meers, Terri D. Bryson, Steven Henikoff · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  86. The CUT&RUN Blacklist of Problematic Regions of the Genome
    Anna Nordin, Gianluca Zambanini, Pierfrancesco Pagella, Claudio Cantù · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Leukemia core transcriptional circuitry is a sparsely interconnected hierarchy stabilized by incoherent feed-forward loops
    Taku Harada, Jérémie Kalfon, Monika W. Perez, Kenneth Eagle, Flora Dievenich Braes, Rashad Batley, Yaser Heshmati, Juliana M. Xavier-Ferrucio, Jazmin Ewers, Stuti Mehta et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Solution structure of the Z0 domain from transcription repressor BCL11A sheds light on the sequence properties of protein‐binding zinc fingers
    Rilee E. Harris, Richard D. Whitehead, Andrei T. Alexandrescu · 2025 · Protein Science
  89. Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model
    Yu Wang, Lei Yu, Kaiwen Deng, Mathivanan Packiarajan, Angelo Aguilar, Sea Yong An, Xiaofang Liu, Greggory Myers, Hoon Oh, Sharon A. Singh et al. · 2025 · Blood
  90. Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT
    Eugenio Marco, Patricia Sousa, Tusneem Janoudi, Edouard De Dreuzy, Jack M. Heath, Ramya Viswanathan, John A. Zuris, Gregory M. Gotta, Georgia Giannoukos, Scott Hansen et al. · 2025 · Molecular Therapy
  91. Curing Sickle Cell Disease by Allogeneic Hematopoietic Stem Cell (HSC) Transplantation Toward In Vivo HSC Gene Therapy
    Rina Kansal · 2025 · Genes
  92. Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma
    Veveeyan Suresh, Christoph Hafemeister, Andri Konstantinou, Sarah Grissenberger, Caterina Sturtzel, Martha Magdalena Zylka, Florencia Cidre‐Aranaz, Andrea Wenninger-Weinzierl, Karla C. S. Queiroz, Dorota Kurek et al. · 2026 · EMBO Molecular Medicine
  93. Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-Globin
    Aisha L. Walker, Danielle E. Crosby, Valerie Miller, Frances L. Weidert, Solomon Fiifi Ofori-Acquah · 2022 · Experimental Hematology
  94. Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
    Jinhe Jiang, Rutong Ren, Yan-jie Cheng, Xinxin Li, Guirong Zhang · 2024 · Frontiers in Cell and Developmental Biology
  95. The non-canonical poly(A) polymerase FAM46C promotes erythropoiesis
    Ke Yang, Tianqi Zhu, Jiaying Yin, Qiaoli Zhang, J. Y. Li, Hong Fan, Gaijing Han, Weiyin Xu, Nan Liu, Xiang Lv · 2024 · Journal of genetics and genomics/Journal of Genetics and Genomics
  96. Hydroxyurea reduces the levels of the fetal globin gene repressors ZBTB7A/LRF and BCL11A in erythroid cells in vitro
    Gabriella E. Martyn, Phillip A. Doerfler, Yu Yao, Kate G R Quinlan, Mitchell J. Weiss, Merlin Crossley · 2024 · Journal of sickle cell disease.
  97. A critique review of fetal hemoglobin modulators through targeting epigenetic regulators for the treatment of sickle cell disease
    Ala Chandu, Sivaprakash Ramalingam, Chandra Sekhar Kondapalli Venkata Gowri, Sankaranarayanan Murugesan · 2025 · Life Sciences
  98. Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype
    Ivan Ferrer Vicens, Daniel C. J. Ferguson, Marieangela C. Wilson, Kate J. Heesom, James J. Bieker, Jan Frayne · 2023 · Blood
  99. Molecular basis of a high Hb A2/Hb Fβ-thalassemia trait: a retrospective analysis, genotype-phenotype interaction, diagnostic implication, and identification of a novel interaction withα-globin gene triplication
    Chayada Soontornpanawet, Kritsada Singha, Hataichanok Srivorakun, Wanicha Tepakhan, Goonnapa Fucharoen, Supan Fucharoen · 2023 · PeerJ
  100. Structural insights into the DNA-binding mechanism of BCL11A: The integral role of ZnF6
    Thibault Viennet, Maolu Yin, Abhilash Jayaraj, Woojin Kim, Zhen-Yu Jim Sun, Yuko Fujiwara, Kevin Zhang, Davide Seruggia, Hyuk‐Soo Seo, Sirano Dhe‐Paganon et al. · 2024 · Structure